Stocks
Adaptive Biotechnologies (ADPT) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -19.1 | 2.23 | 1.31 | -5.82 | -84.4 | -123.3 | ||
| Changes by years, y/y, % | -62% | -112% | -41% | -545% | +1 349% | +11.1% | |||
Adaptive Biotechnologies. EV/EBITDA
Adaptive Biotechnologies. EV/EBITDA, changes, %
Adaptive Biotechnologies (ADPT) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | -37.6 | -68.2 | -97.5 | -92.1 | -216.1 | -123.3 | |
| Changes by years, y/y, % | +919% | +1 071% | +1 059% | +448% | +1 185% | |||
| Changes by quarters, q/q, % | +124% | +81% | +43% | -6% | +135% | |||
